Bionano Genomics

BNGO

Market cap $12.2M

BNGO Hedge Fund Activity: Q1 2026 in Review

32 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2026, worth a combined $1.02M — down 25% from $1.35M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BNGO positions and 8 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $129K. The largest seller was DRW Securities, exiting entirely with an estimated $258K sold.

• 32 institutional investors held Bionano Genomics (BNGO) as of Q1 2026, unchanged from Q4 2025.
• Funds reported $1.02M of Bionano Genomics stock for Q1 2026, down 25% quarter-over-quarter.
• 9 funds opened new Bionano Genomics positions in Q1 2026 and 8 closed out, a net change of +1 holder.
• The largest Bionano Genomics buyer in Q1 2026 was Geode Capital Management, an estimated $129K added.
• The largest Bionano Genomics seller in Q1 2026 was DRW Securities, an estimated $258K sold.

Based on aggregated 13F filings for Q1 2026.